145 related articles for article (PubMed ID: 16707977)
1. 6-Thioguanine-related chronic hepatotoxicity and variceal haemorrhage in children treated for acute lymphoblastic leukaemia--a dual-centre experience.
Ravikumara M; Hill FG; Wilson DC; Gillett PM; Thomas A; Brown R; Darbyshire PJ; McKiernan PJ
J Pediatr Gastroenterol Nutr; 2006 May; 42(5):535-8. PubMed ID: 16707977
[TBL] [Abstract][Full Text] [Related]
2. Portal hypertension develops in a subset of children with standard risk acute lymphoblastic leukemia treated with oral 6-thioguanine during maintenance therapy.
Broxson EH; Dole M; Wong R; Laya BF; Stork L
Pediatr Blood Cancer; 2005 Mar; 44(3):226-31. PubMed ID: 15503293
[TBL] [Abstract][Full Text] [Related]
3. The thiopurine methyltransferase genetic polymorphism is associated with thioguanine-related veno-occlusive disease of the liver in children with acute lymphoblastic leukemia.
Lennard L; Richards S; Cartwright CS; Mitchell C; Lilleyman JS; Vora A;
Clin Pharmacol Ther; 2006 Oct; 80(4):375-83. PubMed ID: 17015055
[TBL] [Abstract][Full Text] [Related]
4. Long-term follow-up of children with 6-thioguanine-related chronic hepatoxicity following treatment for acute lymphoblastic leukaemia.
Rawat D; Gillett PM; Devadason D; Wilson DC; McKiernan PJ
J Pediatr Gastroenterol Nutr; 2011 Nov; 53(5):478-9. PubMed ID: 21701407
[TBL] [Abstract][Full Text] [Related]
5. Chronic liver disease related to 6-thioguanine in children with acute lymphoblastic leukaemia.
De Bruyne R; Portmann B; Samyn M; Bansal S; Knisely A; Mieli-Vergani G; Dhawan A
J Hepatol; 2006 Feb; 44(2):407-10. PubMed ID: 16226335
[TBL] [Abstract][Full Text] [Related]
6. Substitution of oral and intravenous thioguanine for mercaptopurine in a treatment regimen for children with standard risk acute lymphoblastic leukemia: a collaborative Children's Oncology Group/National Cancer Institute pilot trial (CCG-1942).
Jacobs SS; Stork LC; Bostrom BC; Hutchinson R; Holcenberg J; Reaman GH; Erdmann G; Franklin J; Neglia JP; Steinberg SM; Balis FM; Adamson PC; ;
Pediatr Blood Cancer; 2007 Sep; 49(3):250-5. PubMed ID: 16856155
[TBL] [Abstract][Full Text] [Related]
7. A multicenter assessment of liver toxicity by MRI and biopsy in IBD patients on 6-thioguanine.
Seiderer J; Zech CJ; Reinisch W; Lukas M; Diebold J; Wrba F; Teml A; Chalupna P; Stritesky J; Schoenberg SO; Schima W; Göke B; Ochsenkühn T
J Hepatol; 2005 Aug; 43(2):303-9. PubMed ID: 15964660
[TBL] [Abstract][Full Text] [Related]
8. 6-thioguanine associated nodular regenerative hyperplasia in patients with inflammatory bowel disease may induce portal hypertension.
Ferlitsch A; Teml A; Reinisch W; Ulbrich G; Wrba F; Homoncik M; Gangl A; Peck-Radosavljevic M; Vogelsang H
Am J Gastroenterol; 2007 Nov; 102(11):2495-503. PubMed ID: 17894846
[TBL] [Abstract][Full Text] [Related]
9. Frequency of gastropathy and gastric varices in children with extrahepatic portal venous obstruction treated with sclerotherapy.
Poddar U; Thapa BR; Singh K
J Gastroenterol Hepatol; 2004 Nov; 19(11):1253-6. PubMed ID: 15482531
[TBL] [Abstract][Full Text] [Related]
10. Long-term risk of portal hypertension and related complications in children treated with 6-thioguanine for acute lymphoblastic leukemia: A single-center experience.
Roy Moulik N; M Taj M
Pediatr Blood Cancer; 2017 Oct; 64(10):. PubMed ID: 28233441
[TBL] [Abstract][Full Text] [Related]
11. Absence of nodular regenerative hyperplasia after low-dose 6-thioguanine maintenance therapy in inflammatory bowel disease patients.
de Boer NK; Zondervan PE; Gilissen LP; den Hartog G; Westerveld BD; Derijks LJ; Bloemena E; Engels LG; van Bodegraven AA; Mulder CJ
Dig Liver Dis; 2008 Feb; 40(2):108-13. PubMed ID: 18083079
[TBL] [Abstract][Full Text] [Related]
12. Endoscopic treatment of esophagogastric variceal bleeding in patients with noncirrhotic extrahepatic portal vein thrombosis: a long-term follow-up study.
Spaander MC; Darwish Murad S; van Buuren HR; Hansen BE; Kuipers EJ; Janssen HL
Gastrointest Endosc; 2008 May; 67(6):821-7. PubMed ID: 18206153
[TBL] [Abstract][Full Text] [Related]
13. Hepatotoxicity of 6-mercaptopurine in childhood acute lymphocytic leukemia: pharmacokinetic characteristics.
Berkovitch M; Matsui D; Zipursky A; Blanchette VS; Verjee Z; Giesbrecht E; Saunders EF; Evans WE; Koren G
Med Pediatr Oncol; 1996 Feb; 26(2):85-9. PubMed ID: 8531858
[TBL] [Abstract][Full Text] [Related]
14. [Upper gastrointestinal bleeding in patients with portal hypertension--review of clinical cases from 2002-2008].
Kordiak J; Wcisło S; Santorek-Strumiłło E; Bartkowiak R; Brocki M; Misiak P
Pol Merkur Lekarski; 2009 May; 26(155):488-90. PubMed ID: 19606706
[TBL] [Abstract][Full Text] [Related]
15. Toxicity and efficacy of 6-thioguanine versus 6-mercaptopurine in childhood lymphoblastic leukaemia: a randomised trial.
Vora A; Mitchell CD; Lennard L; Eden TO; Kinsey SE; Lilleyman J; Richards SM; ;
Lancet; 2006 Oct; 368(9544):1339-48. PubMed ID: 17046466
[TBL] [Abstract][Full Text] [Related]
16. Pediatric gastroesophageal varices: treatment strategy and long-term results.
Mitsunaga T; Yoshida H; Kouchi K; Hishiki T; Saito T; Yamada S; Sato Y; Terui K; Nakata M; Takenouchi A; Ohnuma N
J Pediatr Surg; 2006 Dec; 41(12):1980-3. PubMed ID: 17161186
[TBL] [Abstract][Full Text] [Related]
17. Long-term follow-up of children with extrahepatic portal vein obstruction: impact of an endoscopic sclerotherapy program on bleeding episodes, hepatic function, hypersplenism, and mortality.
Maksoud-Filho JG; Gonçalves ME; Cardoso SR; Gibelli NE; Tannuri U
J Pediatr Surg; 2009 Oct; 44(10):1877-83. PubMed ID: 19853741
[TBL] [Abstract][Full Text] [Related]
18. Chronic liver failure induced by long-term administration of tegafur: a case report.
Matsumoto M; Nakao K; Matsumoto H; Iwata K; Ohta Y; Kanai K; Takahashi K; Akima M
Hepatogastroenterology; 1998; 45(24):2372-5. PubMed ID: 9951926
[TBL] [Abstract][Full Text] [Related]
19. Hepatotoxicity during 6-thioguanine treatment in inflammatory bowel disease and childhood acute lymphoblastic leukaemia: A systematic review.
Toksvang LN; Schmidt MS; Arup S; Larsen RH; Frandsen TL; Schmiegelow K; Rank CU
PLoS One; 2019; 14(5):e0212157. PubMed ID: 31125338
[TBL] [Abstract][Full Text] [Related]
20. Novel developments in esophageal vascular disorders.
de Franchis R; Dell'Era A
Curr Opin Gastroenterol; 2008 Jul; 24(4):490-5. PubMed ID: 18622165
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
